The Most Innovate Cannabis Stocks on the ASX

By ,

22 January 2015 — a day to remember.

For most people it was probably just another Thursday. They probably got up, dragged themselves to work, came home and thought nothing of it.

How naïve they were.

The ignorant amongst us, including yours truly at the time, didn’t appreciate that history was being made. In fact the vast majority didn’t even have a clue what was happening.

But, for those lucky few that were there, it will be a day that they remember for years to come. It was the day that cannabis made its debut on the ASX.

And what a debut it was…

MMJ Phytotech Ltd [ASX:MMJ] was the belle of the ball. Officially listing at 20 cents per share, speculators were chomping at the bit to get their hands on the first Australian pot play.

In just its second day of trading the stock peaked at an intra-day high of 92 cents! A 360% gain in less than 48 hours.

It set the tone for what would become one of the hottest markets in recent history. And today you can still see echoes of that same explosiveness.

The difference is now there is more than just one company. There is an entire sector filled with companies hoping to turn pot into massive profits.

Get our research on the ‘Top 3 Pot Stocks for 2019.’ The report can be downloaded for free here.

As an investor, it presents a once in a lifetime opportunity. A chance to be a part of a revolution that is set to change the world forever.

Here is a list of just some of the pot stocks you will find on the ASX:

Algae.tec Ltd
Lifespot Health Ltd
AusCann Group Holdings
Medlab Clinical Ltd
BOD Australia Ltd
MGC Pharmaceuticals Ltd
Botanix Pharmaceuticals
MMJ Phytotech Ltd
Cann Group Ltd
Queensland Bauxite Ltd
Cannpal Animal Therapeutics Ltd [ASX:CP1] Rhinomed Ltd
Chapmans Ltd
Roto-Gro International Ltd [ASX:RGI]
Creso Pharma Ltd
Stemcell United Ltd
Elixinol Global Ltd
Hydroponics Company Ltd [ASX:THC]
eSense-lab Ltd
TPI Enterprises Ltd [ASX:TPE]
Eve Investments Ltd [ASX:EVE] Zelda Therapeutics Ltd [ASX:ZLD]

Keep in mind this list isn’t definitive either. This is a turbulent industry with companies dropping in and out fairly regularly.

At the very least though it should give you a good place to start researching this industry. From here you can start delving deeper into the world of pot stocks in Australia.

Be careful though! Its one hell of a deep rabbit hole, and you might find it hard to turn back once you start delving deeper.

If you’re willing to learn and put in the work, though, it could be very rewarding.

Most important of all though is to remember that no two stocks are alike.

Every single one of the companies listed above is offering something unique. Sometimes they may seem similar at face-value, but dig a little deeper and you will find the critical nuances.

Here are three major areas you can find cannabis in right now:

The common theme is health

As you may have noticed a lot of the companies on the list have one thing in common: health. It’s all in the name really, with titles like ‘pharma’ and ‘therapeutics’.

Straight away that should tip you off about the sort of company you’re dealing with. These companies read and operate like biotechs — it just so happens that their drug of choice is cannabis.

And their goal is to show Australia and the world the power of medical marijuana.

Take Medlab Clinical Ltd [ASX:MDC] for example. The company is working on a high-strength cannabis painkiller for cancer patients. A product that if successful could replace the need for opioid-based painkillers.

Medlab’s product is called NanaBis, an oral spray that delivers a targeted dose of cannabis with ease and precision.

This is a product that has been developed and perfected in the lab. It will face clinical trials and testing just like any other drug.

They’re just one of the many companies hoping to profit from cannabis’ miracle properties. Stocks that are knee-deep in research and trials.

These are the companies that are poised to usher in a new frontier of medicine. One that has been kept under lock and key for far too long.

The Three Most Exciting Pot Stocks on the ASX Right Now

Hemp-based food

Not everything is about medicine though when it comes to pot stocks. You may have heard that some people actually like to consume cannabis…for fun.

In Australia this is obviously still a criminal offence. But, that hasn’t stopped some companies from looking for ways to sell some ‘green’ food.

Top of this consumer-based list is EVE Investments Ltd [ASX:EVE] and Elixinol Global Ltd [ASX:EXL].

Both of these companies have one thing in common, and no it’s not cannabis. Instead both Eve and Elixinol are actively marketing and selling hemp-based food.

Hemp, is a plant that is very similar to cannabis. In fact the two are often confused. But, the difference is that hemp won’t get you high. It does contain the same active chemicals, but there’s so little that you’ll never feel a thing.

However, while it won’t get you high, hemp is packed with a lot of other great proteins, fats and vitamins. And both Eve and Elixinol are hoping people are also going to love the taste.

It may sound strange, but hemp and cannabis infused food and drinks are really picking up steam. And companies are betting big on people going ga-ga for a taste of the green stuff.

Green thumbs

At the end of the day someone has to actually grow this stuff. Whether people want it for pain relief, eating, drinking, smoking or whatever else — someone has to produce some plant material.

Luckily we’re pretty good at growing plants in Australia. And cannabis will be no different.

This is without a doubt the biggest market for pot stocks right now. We simply need to produce enough product for ourselves and eventually the world.

On our list you’ll find a lot of companies that are getting into the cultivating business. It’s an obvious choice for most companies that plan to work with cannabis.

However, there are also a few stocks that could profit from this influx of new growers.

For instance, Roto-Gro International Ltd [ASX:RGI] doesn’t actually sell or buy cannabis at all. Instead, they sell a unique rotary hydroponic system designed specifically for growing the plant itself.

The idea is to give cultivators and farmers a tool that lets them grow pot more effectively. A niche little way of profiting from the cannabis boom without having to dance around law.

Roto-Gro aren’t the only company like this either. You can find plenty of companies that could fit somewhere in the cannabis supply chain.

And just like any other industry, when demand is booming, everyone along the supply chain benefits.

This is just a small glimpse at what you can find on the ASX however.

If you’re serious about investing in pot stocks then take the time to look through each company carefully. A smart investor is an informed investor.

It’s a volatile industry, but there is a lot of potential for some serious gains.

This is your chance to be a part of history this time around. A chance to be involved in something bigger than all of us.

Don’t let it be just another ordinary day.


Ryan Clarkson-Ledward,
Contributing Editor, Money Morning

PS: In a brand-new report titled ‘Top Three Pot Stocks for 2019’, Sam Volkering reveals pot players dominating the local and global markets for legal marijuana.

About Ryan Clarkson-Ledward

Ryan Clarkson-Ledward is an Editor at Money Morning.

Ryan holds degrees in both communication and international business. He helps bring Money Morning readers the latest market updates, both locally and abroad. Ryan tackles all the issues investors need to know about that the mainstream media neglects.

Ryan is also the Editor…

Incannex Healthcare Shares Up on Arthritis Treatment Test (ASX:IHL)

Incannex Healthcare share price [ASX:IHL] is up today after its ASX update shows positive results from IHL’s arthritis treatment test. The Incannex share price is up 9.7% as of 3:00pm today…

Elixinol Share Price Up 12% after Acquiring CannaCare Health (ASX:EXL)

Elixinol Global Ltd [ASX:EXL] share price is up today after agreeing to acquire Germany’s leading CBD brand. The EXL share price is now up 25% YTD, but still down from the 52-week high of 47.5 cents.

Medlab Clinical Share Price Down on Latest Results (ASX:MDC)

The share price of Medlab Clinical Ltd [ASX:MDC] is down more than 2%, trading at 33.5 cents. After an impressive run-up, the MDC share price is now starting to move closer to its January heights where it went as high as 42 cents…

Elixinol Share Price Gets Small Boost on Turnaround (ASX:EXL)

After a ripper period in early 2019, the Elixinol Global Ltd [ASX:EXL] share price went on a long-term slide. On a day where the EXL share price was up 3.33% to trade at 15.5 cents, we take a look at the numbers from EXL quarterly update…

Elixinol Share Price Down: Two Thoughts on its Future

After going to almost $6 a share, it is going for almost a tenth of this price today. We look at what has happened to the Elixinol share price and the company’s restructure.

Why ASX Cannabis Stocks are Down — Should You Invest?

It’s been a tough year for ASX cannabis stocks with many companies shedding value over a 12-month window. Only Althea has emerged from the last year with a gain to show for it. It’s worth taking a look at the ETFMG Alternative Harvest ETF chart to see what’s happening to cannabis stocks globally….